Updated:
Jiangsu Yuyue Medical Equipment & Supply
Wu Guangming founded Yuwell in 1998 in Danyang, Jiangsu province, building a specialized manufacturer of homecare medical devices — oxygen concentrators,...
Jiangsu Yuyue Medical Equipment & Supply
Wu Guangming founded Yuwell in 1998 in Danyang, Jiangsu province, building a specialized manufacturer of homecare medical devices — oxygen concentrators, nebulizers, and blood pressure monitors. The company's products became ubiquitous in Chinese hospitals and households, and it listed on the Shenzhen Stock Exchange. Founder's son Wu Qun now serves as Chairman and CEO, and under his leadership the company has formalized corporate investment activities. Yuwell operates as a corporate venture investor targeting the medical equipment and digital health ecosystems. The firm co-invested with Tencent and Sequoia Capital China in healthcare rounds, including strategic backing of its own subsidiary Xunjie Medical, which focuses on smart, connected respiratory devices. Beyond pure venture, Yuwell deploys capital directly into expanding its manufacturing footprint, operating production bases in Danyang and research centers globally. Confirmed investment areas span respiratory care, chronic disease management, and diagnostic hardware. The firm maintains three principal operations hubs in Danyang, Nanjing's Xuzhuang Software Park, and Shanghai. No separate venture fund vehicle is publicly disclosed; investment activity appears interwoven with the parent corporation's balance sheet. Yuwell serves as the Chairman unit of the Chinese Medical Equipment Industry Association, a position that embeds it deeply in regulatory and supply-chain networks. The family also operates Yuwell Medical CSR Initiatives for philanthropic giving. In March 2024, Wu Qun outlined commercial steps to expand international distribution networks for the firm's core respiratory devices (per Reuters, 2024). Yuwell's structural differentiator is its identity as a publicly listed operating company that functions as a corporate VC — combining in-house R&D, large-scale government-tied manufacturing, and strategic venture checks without a separate fund management layer. This allows investments to function simultaneously as R&D pipeline expansion and supply-chain control, rather than pure financial return vehicles. The leadership succession from founder Wu Guangming to his son Wu Qun further characterizes the firm as a hybrid between family enterprise and public corporate structure.
General information
Firm type
Corporate Investor
Year founded
1998
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Danyang
Corporate office
No. 1 Baisheng Road, Development Zone, Danyang, Jiangsu, China
Additional offices
Nanjing, Jiangsu, China · Shanghai, China
Principals
Wu Qun
Chairman and CEO
Wu Guangming
Founder
Sector focus
Frequently asked questions
Who runs investment decisions at Yuwell?
Investment decisions ultimately flow through Chairman and CEO Wu Qun, son of founder Wu Guangming. The firm does not disclose a separate CIO or investment committee for corporate venture activity, suggesting capital allocation is managed through the parent company's executive leadership.
Does Yuwell operate a dedicated venture fund?
No dedicated venture fund is publicly disclosed. Yuwell invests via its corporate balance sheet and operates Xunjie Medical, a subsidiary focused on smart respiratory devices, which received strategic investment from Tencent. All known deployment is direct rather than through a separate limited partnership structure.
What healthcare subsectors does Yuwell target for investment?
Yuwell concentrates on homecare medtech, including respiratory care and chronic disease management devices. The firm also backs digital health ventures that connect diagnostic hardware to telemedicine platforms, reflecting the parent company's existing expertise in oxygen concentrators and blood pressure monitors.
Which co-investors participate in Yuwell's venture deals?
Tencent Holdings and Sequoia Capital China are the two named co-investors in prior Yuwell-related healthcare investment rounds, per public record. The firm's industry association chairmanship also suggests deep state-affiliated capital links, though these are not formally disclosed as co-investors.
How is Yuwell related to Xunjie Medical?
Xunjie Medical is a subsidiary of Yuwell focused on internet-connected respiratory care devices. Tencent became a strategic investor in Xunjie Medical, making it a key vehicle for Yuwell's digital health push while the parent company retains operational control.
Does Yuwell maintain active philanthropic programs?
Yes. Yuwell Medical CSR Initiatives handles the family's corporate social responsibility programs. The firm has directed medical device donations and pollution-related health support efforts in China, though it does not disclose a separate foundation entity.
What is Yuwell's approach to manufacturing versus investment?
Yuwell treats venture investment as an extension of its manufacturing ecosystem, not a standalone financial activity. Capital deployment often takes the form of direct subsidiary creation or strategic enterprise investment that simultaneously secures technology access, supply-chain coverage, and channel expansion for core device product lines.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: